ConductScience.org, home

Paper698935

Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.

Heppner GH and 4 others. Cancer Res, 1978. Cited by 295 papers, by iCite.

Cite this record

ConductScience Library. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Papers, record 698935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/698935

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
PubMed
Journal
Cancer Res
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
295
iCite
Relative citation ratio, by iCite
6.62
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heppner GHG H
2Dexter DLD L
3DeNucci TT
4Miller FRF R
5Calabresi PP

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Antineoplastic AgentsMajor topic
Mammary Neoplasms, ExperimentalMajor topic
Animals
Cell Line
Cyclophosphamide
Drug Resistance
Fluorouracil
Male
Methotrexate
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Neoplasm Metastasis
Remission, Spontaneous
Time Factors

Source PubMed

Download CSV of topics

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 295 citations.

PMIDTitleJournalYearIn PapersSource
42293745Metabolic reprogramming and plasticity of cancer stem cells.Front Cell Dev Biol2026https://conductscience.org/library/papers/42293745PubMed
42193921Advances in Immunotherapies for Targeting Cancer Stem Cells in a Tumor Microenvironment: Emerging Strategies and Clinical Prospects.Cells2026https://conductscience.org/library/papers/42193921PubMed
40759634Cancer stem cells: landscape, challenges and emerging therapeutic innovations.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40759634PubMed
39337633Sonodynamic Therapy for HER2+ Breast Cancer with Iodinated Heptamethine Cyanine-Trastuzumab Conjugate.Int J Mol Sci2024https://conductscience.org/library/papers/39337633PubMed
38435793Relatively Rare Populations of Invasive Cells Drive Progression of Heterogeneous Tumors.Cell Mol Bioeng2024https://conductscience.org/library/papers/38435793PubMed
34473289Anticancer potential of (-)-epicatechin in a triple-negative mammary gland model.J Pharm Pharmacol2021https://conductscience.org/library/papers/34473289PubMed
33959849Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.Cancer Metastasis Rev2021https://conductscience.org/library/papers/33959849PubMed
32195244In vitro Models of Breast Cancer Metastatic Dormancy.Front Cell Dev Biol2020https://conductscience.org/library/papers/32195244PubMed
31783695Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model.Cancers (Basel)2019https://conductscience.org/library/papers/31783695PubMed
31623133The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?Cancers (Basel)2019https://conductscience.org/library/papers/31623133PubMed
31597954HUNK phosphorylates EGFR to regulate breast cancer metastasis.Oncogene2020https://conductscience.org/library/papers/31597954PubMed
31205572BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance.J Cancer2019https://conductscience.org/library/papers/31205572PubMed
29732370Microenvironmental Signals and Biochemical Information Processing: Cooperative Determinants of Intratumoral Plasticity and Heterogeneity.Front Cell Dev Biol2018https://conductscience.org/library/papers/29732370PubMed
29218910Pan-cancer analysis of expressed somatic nucleotide variants in long intergenic non-coding RNA.Pac Symp Biocomput2018https://conductscience.org/library/papers/29218910PubMed
29123422Neutrophil-Derived Interleukin 16 in Premetastatic Lungs Promotes Breast Tumor Cell Seeding.Cancer Growth Metastasis2017https://conductscience.org/library/papers/29123422PubMed
27751894Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.Biochim Biophys Acta2016https://conductscience.org/library/papers/27751894PubMed
27228477Characterization of Cell-Type-Specific Drug Transport and Resistance of Breast Cancers Using Tumor-Microenvironment-on-Chip.Mol Pharm2016https://conductscience.org/library/papers/27228477PubMed
26305796Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.PLoS One2015https://conductscience.org/library/papers/26305796PubMed
26175968Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer.Front Oncol2015https://conductscience.org/library/papers/26175968PubMed
25962957Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer.Oncotarget2015https://conductscience.org/library/papers/25962957PubMed

See all 74 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/698935

GET https://conductscience.org/api/papers/v1/698935/cited_by?page=2